Safety and efficacy of sirolimus in recurrent intravenous leiomyomatosis, pulmonary benign metastatic leiomyomatosis, and leiomyomatosis peritonealis disseminata: a pilot study

Abstract Background Intravenous leiomyomatosis (IVL), pulmonary benign metastatic leiomyomatosis (PBML), and leiomyomatosis peritonealis disseminata (LPD) are leiomyomas with special growth patterns and high postoperative recurrence rates. We report the safety and efficacy of a pilot study of siroli...

Повний опис

Бібліографічні деталі

Автори:	Guorui Zhang, Rong Fan, Hua Yang, Hao Su, Xin Yu, Yutong Wang, Fengzhi Feng, Lan Zhu
Формат:	Artigo
Мова:	Inglês
Опубліковано:	BMC 2024-03-01
Серія:	BMC Medicine
Предмети:	Sirolimus mTOR inhibitor Intravenous leiomyomatosis Pulmonary benign metastatic leiomyomatosis Leiomyomatosis peritonealis disseminata
Онлайн доступ:	https://doi.org/10.1186/s12916-024-03344-9
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!